Osteopenia Completed Phase 4 Trials for Raltegravir (DB06817)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00939874Switch From Tenofovir to Raltegravir for Low Bone Mineral DensityTreatment